Favicon
Favicon

HIV Vaccines to be Tested at the Disease’s Epicenter

Date: October 9, 2012 By:

“An international research consortium plans to begin testing four new HIV vaccines in 2014 in a province of South Africa where the infection rate is among the highest in the world.

 

The unusual effort to test several vaccines nearly simultaneously reflects the difficulty of finding a way to prevent HIV infection, says Bruce Walker, a Harvard Medical Scho­­ol professor and one of the founding scientists of a new research center opening this month in Durban, in KwaZulu-Natal province, where the tests will occur.”

 

read the rest of the MIT Technology Review article

More News

Todd Allen

We are deeply saddened to announce the passing of Ragon Institute faculty member Todd M. Allen, PhD, a pioneering researcher in T cell immunotherapy and HIV evolution and transmission.

Press Releases

New HIV Vaccine Design Shows Promise in Creating Protective Antibodies

Researchers at the University of Amsterdam, in collaboration with the Batista Lab at the Ragon Institute, have developed a potential new approach for an HIV vaccine.

Groundbreaking Study on Lymph Node Excision Advances HIV Cure Research

Researchers at the Ndhlovu Lab, part of the Ragon Institute and the Africa Health Research Institute (AHRI), have completed a significant study on the safety and practicality of lymph node excisions for HIV cure research in South Africa.